Status:
COMPLETED
Pro-inflammatory Cytokines and Implantation Process in Women With Primary Idiopathic Infertility
Lead Sponsor:
Jagiellonian University
Conditions:
Infertility, Female
Infertility Unexplained
Eligibility:
FEMALE
18-40 years
Brief Summary
Infertility is a common, worldwide problem. In about 20% of couples, the causative agent of infertility cannot be identified after routine diagnostic tests. One of the causes of idiopathic infertility...
Detailed Description
Infertility affects approximately 8 to 12% of reproductive age couples worldwide, equivalent to more than 186 million people. In approximately 20% of couples, the causative agent of infertility canno...
Eligibility Criteria
Inclusion
- Study group
- Inclusion criteria:
- primary infertility (unsuccessfully trying to become pregnant for more than a year)
- regular menstruation
- Exclusion criteria:
- female homronal therapy
- established male factor of infertility
- tubal factor
- endometriosis
- inflammation in the pelvic area - currently and in the history
- hormonal background of infertility
- obesity
- insulin resistance
- status post at least one miscarriage
- chronic autoimmune diseases.
- Control group
- Inclusion criteria:
- naturally conceived offspring up to three years of age
- regular menstruation
- Exclusion criteria were:
- status post surgery on the uterus, including curettage of the uterine cavity
- endometriosis
- pelvic inflammation - present and in the history
- at least one miscarriage
- obesity
- insulin resistance
- chronic autoimmune diseases
- breastfeeding.
Exclusion
Key Trial Info
Start Date :
November 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2020
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT05190250
Start Date
November 1 2017
End Date
November 1 2020
Last Update
January 13 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinic Of Endocrynological Gynecology
Krakow, Malopolska, Poland, 30-501